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Effect of chronic uremia in the rat on cerebral mitochondrial
calcium concentrations
ANDREW J. ADLER and GEOFFREY M. BERLYNE
Department of Medicine, Brooklyn Veterans Administration Hospital, Brooklyn, New York, USA
Effect of chronic uremia in the rat on cerebral mitochondrial calcium
concentrations. Whole cerebral and isolated mitochondrial calcium
levels were determined in normal and chronically uremic Sprague-
Dawley rats. Uremia was induced by a two-stage 5/6 nephrectomy 4
weeks prior to study. Serum was obtained for urea, calcium, magne-
sium, phosphate, and i-PTH. Mitochondria were isolated by gradient
centrifugation and calcium was determined by flameless atomic absorp-
tion spectrophotometry. The results demonstrate that mitochondrial
calcium levels in uremic rats are not different from normal (8.0 2.8
vs. 7.8 1.8 nmoles/mg protein) despite an 11% increase in whole
cerebral calcium concentration (17.3 2.0 vs. 15.5 2.8 nmoles/mg
protein; P < 0.005) in 24 severely uremic rats (BUN > 18.0
mmoles/liter). Multiple regression analysis demonstrates a significant
positive correlation between cerebral calcium concentrations and both
serum calcium (P < 0.005) and serum magnesium levels (P < 0.005). No
relationship was found for urea, serum phosphate, or i-PTH. Similar
analysis of mitochondrial calcium concentration demonstrated a sig-
nificant positive correlation with serum calcium (P < 0.005) and i-PTH(P < 0.05) suggesting that increased PTH may be necessary for
maintaining normal intracellular calcium levels in uremia. We conclude
that uremia in the rat is associated with a small rise in whole cerebral
calcium but that intracellular calcium as reflected by mitochondrial
levels is not elevated.
Effet de l'urémie chronique chez le rat sur les concentrations de calcium
mitochondrial cérébrales. Les niveaux de calcium cérébral total et dans
des mitochondries isolées ont éte déterminés chez des rats Sprague-
Dawley normaux et en urémie chronique. L'urémie a été induite par
une néphrectomie des 5/6 en deux étapes 4 semaines avant l'étude. Du
serum a tC obtenu pour l'urée, Ic calcium, le magnesium, les phos-
phates, et l'i-PTH. Les mitochondries ont été isolées par gradient de
centrifugation et le calcium a été déterminé par spectrophotométrie
d'absorption atomique de flamme. Les résultats montrent que les
niveaux de calcium mitochondrial chez les rats urémiques ne different
pas de la normale (8,0 2,8 contre 7,8 1,8 nmoles/mg protéines)
malgré une augmentation de 11% de Ia concentration calcique cérébrale
totale (17,3 2,0 contre 15,5 2,8 nmoles/mg protéines; P < 0,05)
chez 24 rats sévèrement urémiques (BUN > 18,0 mmoles/litre). Une
analyse en regressions multiples démontre une correlation positive
significative entre les concentrations calciques cérébrales et les niveaux
de calcémie (P < 0,005) et de magnesémie (P < 0,005). Aucune relation
n'a été trouvée pour l'urée, Ia phosphatemie ou l'iPTH. Une analyse
identique de la concentration calcique mitochondriale a démontré une
correlation positive significative avec Ia calcémie (P < 0,005) et l'iPTH
(P < 0,05), suggérant qu'une PTH élevée pourrait Ctre nécessaire pour
maintenir des niveaux de calcium intracellulaires normaux dans
l'urémie. Nous concluons que l'urémie chez Ic rat est associée a une
faible élévation du calcium cérébral total mais que le calcium intracel-
lulaire, reflèté par les niveaux mitochondriaux, n'est pas élevé.
considerable interest in the role of calcium and parathyroid
hormone (PTH) in the pathogenesis of uremic encephalopathy
[5—8]. In 1974, Arieff and Massry [5] first suggested that acute
uremia is associated with an increased calcium concentration in
both grey and white matter of the brain and that these eleva-
tions could be prevented by prior parathyroidectomy. This was
followed by reports in both uremic dogs [6] and humans [7, 8] of
an association between abnormalities in the electroence-
phalogram and the calcium content of the brain. These studies
suggested that neurotoxicity in acute uremia is a consequence
of accumulated calcium by the brain and that this was second-
ary to elevated serum i-PTH. However, in a number of prelimi-
nary studies in our laboratory using a rat model, an increase of
brain calcium in either acute or chronic renal failure could not
be demonstrated [9—11].
A basic question relevant to all these studies is whether
analysis of a whole tissue preparation is indicative of its
intracellular calcium concentration. There is ample evidence to
indicate that from 50 to 90% of tissue calcium may be bound
extracellularly to a glycoprotein calyx [12—141. Consequently,
changes in tissue calcium as reported for the brain in uremia
may merely reflect changes in the quantity of calcium bound to
extracellular ligands and not true changes in the physiologically
important intracellular fraction.
To better assess the effect of uremia on intracellular brain
calcium, we chose to study the calcium content of isolated
mitochondria in addition to whole brain tissue. The mitochon-
dna, which contain the largest proportion of the intracellular
calcium [12, 15, 161, are thought to regulate cytoplasmic cal-
cium and buffer excess calcium entering the cell [17—201. Thus,
any long-term alterations in intracellular calcium therefore
might be expected to be reflected by changes in the mito-
chondrial calcium content.
Methods
Animals. Adult male Sprague-Dawley rats (Charles River
Laboratories, Wilmington, Massachusetts, USA) weighing 250
to 400 g at the time of sacrifice were used in all experiments.
Experimental groups consisted of normal and chronically ure-
mic rats.
Calcium ions participate in numerous cellular and subcellular
processes and are particularly important for the normal function
of the nervous system [1—4]. Reports of an increased calcium
concentration in the brain associated with uremia have led to
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Table 1. Ramped time temperature program used to heat cuvette in
calcium analysis by atomic absorption spectrophotometry
Step Temperature
Ramp
sec
Hold
sec
1 80 10 30
2 110 10 30
3 900 10 30
4 1600 10 30
5 2800 0 8
6 20 10 20
Induction of chronic uremia. Chronic uremia was induced
following ether anesthesia by means of a two-stage procedure
consisting of a right total nephrectomy followed in 2 weeks by
a left 2/3 bipolar nephrectomy. Animals were maintained for 4
to 6 weeks prior to sacrifice on a standard rat chow diet (Ralston
Purina, St. Louis, Missouri, USA) and tap water ad libitum,
Calcium analysis by atomic absorption spectrophotometry.
Atomic absorption spectrophotometry with graphite furnace
flameless atomization was used to analyze all tissue specimens
for calcium content. An atomic absorption spectrophotometer
(model #703, Perkin Elmer, Norwalk, Connecticut, USA)
equipped with an HGA 500 graphite furnace (Perkin Elmer) was
used. Twenty microliters of sample were pipetted into an
uncoated graphite cuvette of the atomizer. The cuvette was
heated by the ramped time temperature program in Table 1.
Step numbers 5 and 6 in Table 1 were each repeated twice.
This program achieved drying, ashing, and atomization of the
sample. The final four steps were used as burn-offs of the
cuvette to eliminate any potential contamination of the sub-
sequent sample. The absorbance was recorded at 422.7 nm and
no scale expansion was used. The peak height mode of analysis
was used as a measure of the calcium content in the sample.
Each sample was analyzed in triplicate. Water and standard
solutions were repeated in triplicate after each sample. Linear
regression analysis was used to obtain a sensitivity in units of
absorbance/nanogram calcium atomized, and absorbances were
linear over the concentration ranges studied (r = 0.998). The
reproducibility and sensitivity of the method was assessed
repeatedly throughout the course of the study. The percent
recovery of added standard was 98.4%. The intragroup co-
efficient of variation was 1.05% for standard and 1.64% for
tissue samples. The intergroup coefficient of variation was
1.84% for standards and 2.43% for a sample specimen carried
throughout the course of the study. Special procedures to
reduce potential calcium contamination were meticulously fol-
lowed. The water used for all preparations and washing was
ultrapure reagent grade water prepared by means of a milli
reagent grade water system (R. 0. and Milli-Q, Worthington
Diagnostics, Millipore, Bedford, Massachusetts, USA). The
calcium concentration of this water was consistently below 1
ng/ml. All glass vessels used for analytical solutions or samples
were washed by rinsing with ultrapure water, followed by
analytical grade HCI 10% (Ultrex, J. T. Baker Chemical Co.,
Phillipsburg, New Jersey, USA) and rinsing again with
ultrapure deionized water. All commercially purchased re-
agents were of analytical grade when available.
Biochemical determinations in serum. Serum calcium and
magnesium concentrations were measured by atomic absorp-
tion spectrophotometry (IL model #251, Worthington, Mas-
sachusetts, USA) using air/acetylene flame. Ten percent
lanthanum by volume was added to the specimen to minimize
interference by phosphates. Blood urea nitrogen levels were
determined by standard autoanalyzer techniques (Technicon
AAII, Tarrytown, New York, USA). Inorganic phosphate was
determined by the colormetric method of Fiske and SubbaRow
[211. Protein determinations were performed according to the
method of Lowry et al [22], using bovine serum albumin as
standard.
Determination of i-PTH. This was kindly performed by Dr.
R. Shainken-Kestenbaum of Siroka Medical Center, Beer
Sheva, Israel, by radioimmunoassay using the IRE Kit (6220
Fleurus Belgium) antibody to C-terminal fragments 34-84 of
PTH. Results are expressed as milliunits per milliliters. One
milligram is equivalent to 2700 450 IU for the hormone MRC
71/324.
Preparation of cerebral homogenates. Both normal and
uremic rats were fasted overnight but allowed water ad libitum.
Rats were then decapitated and the brain was carefully removed
from the calvarium and rinsed with cold (4°C) deionized water.
The cerebellum and the medulla were dissected free of the
brain; the remaining cerebrum was weighed on an analytical
balance (Mettler Model H54 AR, Princeton, New Jersey,
USA). The brain was then homogenized with 8 ml of deionized
water in a homogenizer using eight up and down strokes with a
pestle (Teflon®). All work was performed at 4°C.
Preparation of brain mitochondria. Brain mitochondria were
isolated according to a modification of the method of Clark and
Nicklas [231, All preparative procedures were performed at 4°C.
Rat brains were obtained and processed through the weighing
procedure as described above. The cerebrum was then homog-
enized with 4 ml of cold isolation medium consisting of 0.25 M
sucrose, 10 mM Tris-HC1 pH 7.4, and 0.05 mM EDTA, using
eight up and down strokes with a pestle (Teflon®). An additional
4 ml of isolation medium were added to the homogenate which
was then centrifuged (IEC Model B-20A, Damon IEC Division
Needham Heights, Massachusetts, USA) at x900g for 10 mm at
4°C. The supernatant was again centrifuged at x 12,500g for 8
mm yielding a crude mitochondrial pellet. The pellet was
resuspended in 6 ml of a 4% Ficoll solution containing 0.12 M
mannitol, 0.03 M sucrose, 0.025 EDTA, and 5 mi Tris-HC1, pH
7.4. This was carefully layered over 12 ml of an 8% Ficoll
solution composed of 0.24 M mannitol, 0.06 M sucrose, 0.05
EDTA, and 10 mtvs Tris-HC1, pH 7.4 and centrifuged at x8000g
for 30 mm at 4°C. The supernatant was removed including the
small buffy layer above the mitochondrial pellet. The pellet was
then resuspended in 4 ml of isolation medium and recentrifuged
at x 12,500g for 8 mm. The pellet containing the final mito-
chondrial fraction was then resuspended in trace-element,
quality pure deionized water. Contamination by residual isola-
tion medium retained by the mitochondrial pellet was deter-
mined by means of '4C sucrose (New England Nuclear Corp.,
Boston, Massachusetts, USA) labelling of the isolation medium
and found to be negligible at 0.4% of the recovered calcium.
The use of Ca2 chelator in the isolation medium prevents any
calcium uptake during the preparative procedure, and although
we cannot be absolutely certain, there should be no measurable
calcium effiux from mitochondria during the isolation proce-
dure, as shown by Hughes and Barritt [24] for liver.
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Table 2. Serum composition in normal and uremic ratsa
Concentration in mmoles/liter
UreaN Ca P Mg
Normal 5.94 1.56 (53) 2.55 0.20 (54) 3.19 0.26 (27) 1.18 0.22 (53)
Chronic uremia
Mild
Severe
18.9 6.5 (52)"
14.0 2.4 (25)"
23.4 5.6 (27)"
2.55 0.20 (50)
2.55 0.20 (27)
2.58 0.20 (23)
3.19 0.48 (26)
3.03 0.29 (13)
3.39 0.55 (l3)l
1.36 0.23 (50)"
1.27 0.23 (27)b
1.46 0.19 (23)"
a The number in parentheses indicates the number of animals.
b P < 0.05 compared to normal.
P < 0.0005 compared to normal.
Enzyme determinations. Lactate dehydrogenase and
cytochrome C oxidase activities were used to assess the purity
of the mitochondrial pellet. Assays were performed at 25°C with
a double-beam grating ultraviolet-light spectrophotometer and a
recorder (models 124 and 56, respectively, Perkin Elmer).
Lactate dehydrogenase activity in whole brain and mitochon-
dna was determined by following NADH oxidation at 340 nm in
a medium containing 50 m potassium phosphate, 1 mM
pyruvate, 0.2 m NADH, and 0.5% Triton XlOO at pH 7.4.
Cytochrome C oxidase activity was determined spectrophoto-
metrically in a medium containing 50 m phosphate buffer, pH
7.4, 50 m sucrose, 0.2 mi EDTA, and 0.025 m'vi cytochrome
C which had been fully reduced with Na2S2O4.
Statistical analysis. All data are presented as mean SD and
were analyzed for skewness and kurtosis by means of the model
II Statistical Analysis Program of the TSR 80 Microcomputer
(Tandy Corporation, Fort Worth, Texas, USA), Statistical
analysis included the Student t test for the difference of means
and F ratio for significance of correlation of multiple regression
analysis. Correlation analysis was performed for the relation-
ship of four independent variables to cerebral calcium and
mitochondrial calcium levels. Because i-PTH levels were avail-
able only in relatively small but randomly selected subgroups of
the larger study group, multiple linear regression analysis was
repeated for all four variables evaluated in the larger group plus
i-PTH. The significance of semipartial and partial coefficients
was determined by F ratio.
Results
Serum values for normal and uremic rats are shown in Table
2. The results for uremic rats have been subdivided into mild
uremia (BUN concentrations below 18.0 mmoles/liter) and
severe uremia (BUN concentrations of 18.0 mmoles/liter or
greater) according to the median BUN value for the entire
group. Chronically uremic rats had a mean BUN concentration
of 18.9 6.5 mmoles/liter (52.9 18.1 mg/dl) as compared to
5.94 1.46 mmoles/liter (16.6 4.1 mg!dl) in normal rats (P <
0.003). The mean serum calcium and phosphorous levels did not
significantly differ between the normal and uremic groups taken
as a whole. However, in the severely uremic subgroup, with a
mean BUN concentration of 23.4 5.6 mmoles/liter (65.6
15.8 mgldl), the serum phosphorous was significantly elevated
above controls (3.19 0.26 vs. 3.39 0.55 mmoles/liter; P <
0.05). Serum magnesium concentrations were significantly
higher in the uremic rats at 3.26 0.56 mg/dl compared to 2.83
0.53 mg/dl in normals (P < 0.0005).
Table 3. Cerebral and mitochondrial calcium concentrations in normal
and uremic ratsa
Cerebral Ca
nmoles/mg protein
Mitochondrial Ca
nmoleslmg protein
Normal 15.5 2.8 (45) 8.0 2.8 (26)
Uremic 16.5 2.3 (45) 7.8 1.8 (38)
Mild 15.8 2.3 (21) 7.8 1.8 (21)
Severe 17.3 2.0 (24)" 7.8 1.8 (17)
a The number in parentheses indicates the number of animals.
b P < 0.005 compared to normal animals.
Cerebral protein concentrations were 76.8 10.8 mg/g wet
weight in normal rats and 75.5 7.0 mg/g wet weight in uremic
rats (P = NS). Specific activities of cytochrome C oxidase and
lactate dehydrogenase in cerebral homogenates and mitochon-
drial preparations were measured. The purified mitochondrial
fraction had a negligible content of LDH 0.046 tmoles/min/mg
protein and an enhanced cytochrome oxidase activity 0.85
tmoles/min/mg protein. The enzymatic purity of our mito-
chondrial preparation agrees favorably with that reported in the
literature [15, 23]. The enzyme activities in cerebral homogen-
ates and purified brain mitochondria were not different between
uremic animals and normal controls.
Cerebral calcium levels are shown in Table 3. Mean cerebral
calcium in 45 normal rats was 15.5 2.8 nmoles/mg protein and
did not differ significantly from the mean concentration of 16.5
2.3 nmoles/mg protein in 45 uremic rats. Similarly, brain
mitochondrial calcium concentrations did not differ between
groups, with a mean of 8.0 2.8 nmoles/mg protein in 26
normal rats and 7.8 1.8 nmoles/mg protein in 38 uremic rats.
However, when the uremic subgroups are individually com-
pared to the normal controls, the severely uremic subgroup
demonstrates a significantly higher total cerebral calcium con-
centration of 17.3 2.0 nmoles/mg protein (P < 0.005). A
similar result was not observed for mitochondrial calcium
which remained identical in both uremic subgroups.
The results of multiple regression analysis for both cerebral
calcium and mitochondrial calcium are as follows: Cerebral
calcium levels correlated positively with serum calcium [partial
regression coefficient (pr) = 0.33; P < 0.005; Fig. 1] and serum
magnesium concentration (pr = 0.34, P < 0.005; Fig. 2).
Mitochondrial calcium levels correlated only with serum cal-
cium levels (pr = 0.45; P < 0.005; Fig. 3). Neither serum
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Fig. 1. Relationship between cerebral Ca concentration (mmoles/mg
Pr) and serum Ca concentration (mmoles/liter) in normal and uremic
rats. The correlation coefficient and probability shown on the graph are
derived from univariate analysis of the two variables; the partial
correlation coefficient and its probability derived from multiple regres-
sion analysis are given in Results.
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Fig. 3. Relationship between mitochondrial Ca (nmoles/mg protein) and
serum Ca (mmoles/liter) in normal and uremic rats. The correlation
coefficient and probability shown on the graph are derived from
univariate analysis of the two variables; the partial correlation co-
efficient and its probability derived from multiple regression analysis
are given in Results.
Table 4. Serum composition and brain calcium levels in the subgroup
of animals for which i-PTH levels were obtaineda
22.5 -
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E
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7.5
Normal (12) Uremic (16)
Serum urea N, mmoles/liter 5.57 1.56 17.6 4.4"
Serum Ca, mmoles/liter 2.53 0.13 2.60 0.20
Serum P, mmoles/liter 3.14 0.15 3.11 0.23
Serum Mg, mmoles/liter 1.13 0.18 1.39 0.l6c
Serum i-PTH, mU/mi 4.8 2.3 8.2 34C
Cerebral calcium, nmoles/mg
protein 14.3 2.0 15.8 2.0
Mitochondrial calcium,
nmoles/mg protein 7.8 1.8 8.3 1.8
I I
_______________________________________________ a The number in parentheses indicates the number of animals.
1 1.25 1.5 1.75 2.0 b P < 0.05.
Serum Mg, mmoles/iiter P < 0.0005.
Fig. 2. Relationship between cerebral Ca (mmoles/mg protein) and the
serum Mg (mmoles/liter) in normal and uremic rats. The correlation
coefficient and probability shown on the graph are derived from
univariate analysis of the two variables; the partial correlation co-
efficient and its probability derived from multiple regression analysis
are given in Results.
phosphate nor BUN demonstrated any significant relationship
to cerebral or mitochondrial calcium.
In a subgroup of 28 animals, serum i-PTH levels were
obtained (Table 4). Mean i-PTH was 4.8 2.3 mU/mi in 12
normal rats and 8.2 3.4 mU/ml in 16 uremic rats (P < 0.05).
Consistent with the results obtained in the larger population,
neither cerebral calcium nor mitochondrial calcium differed
between normal and uremic rats. The uremic group was not
further subdivided into mild and severe uremia because of the
relatively small sample size. Results of multiple regression
analysis in this subgroup were identical to those of the larger
population with the additional observation that i-PTH cor-
related positively with mitochondrial calcium levels (pr = 0.34;
P < 0.05; Fig. 4). A similar relationship was not observed for
cerebral calcium.
Discussion
The results of this study suggest that progressive renal failure
in the rat is associated with a rise in the calcium content of
cerebral homogenates. This finding differs from our preliminary
observations [9—111, and that of Smythe et al [251, but is
consistent with previous reports in other species [5—81. The
mean increase in cerebral calcium was 11% above normal and
was demonstrable only in the severely uremic subgroup. This
figure is considerably lower than either the 50% increase
reported by Arieff and Massry [5] in acutely uremic dogs or the
q)
0
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Fig. 4. Relationship between mitochondrial Ca (nmoleslliter) and serum
i-PTH (mU/mI) in a subgroup of normal and uremic rats. The correla-
tion coefficient and probability shown on the graph are derived from
univariate analysis of the two variables, partial correlation coefficient
and its probability are derived from multiple regression analysis and are
given in Results.
52 and 73% increases reported respectively by Cogan et a! [8]
and Cooper, Lazarowitz, and Arieff [71 in uremic humans. A
recent report by Mahoney and Arieff [26] suggests that calcium
levels are elevated only in cortical gray matter and hypo-
thalamus, which possibly might account for our lower value.
When the data were further evaluated by multiple regression
analysis, it was found that the BUN concentration contributed
negligibly to the level of cerebral calcium. Only the serum
calcium and serum magnesium concentrations demonstrated a
significant relationship to cerebral calcium levels. A relation-
ship between the extracellular calcium concentration and tissue
calcium levels has been shown in vitro for a variety of tissues
including kidney, liver, muscle, and brain [27—311. In vivo, the
results have been somewhat less consistent but generally sup-
port the in vitro observations. Wallach et al [321, studying tissue
distribution of the 47Ca in acutely hypercalcemic dogs, con-
cluded that the cellular calcium of brain was largely
unexchangeable and was not altered by changes in extracel-
lular calcium. However, these animals were studied over a
relatively short time period of 4 hr. In studies carried out over
a longer time frame, Mulryan et al [331 showed that the brain
equilibrates very slowly with extracellular calcium requiring up
to 4 days for complete equilibration. Harris, Carness, and Forte
[31] also found a relationship between extracellular calcium and
brain calcium and reported decreases of brain calcium levels in
rats rendered chronically hypocalcemic by diets deficient in
either calcium or vitamin D.
The failure of other investigators to demonstrate a similar
relationship in uremia may be due to a variety of factors
including species differences, the small sample size used in
those studies, and the relatively short time interval between the
induction of uremia and sacrifice of the animal. As our animals
were in a steady-state for at least 4 weeks prior to sacrifice, it
can be expected that any long-term changes in the extracellular
calcium level would also be reflected in the brain tissue.
Our results also suggest that there is no direct relationship
between cerebral calcium and serum i-PTH, a finding in contra-
distinction to that reported by Arieff and Massry [51 but
consistent with other observations made in nonuremic condi-
tions. Mulryan et al [33] reported that PTH had no effect on the
equilibration of extracellular calcium with tissue calcium and
Harris, Carness, and Forte [311 found that despite a sevenfold
increase in i-PTH, brain calcium was decreased in their
hypocalcemic rats.
The finding of a significant positive correlation between brain
calcium and serum magnesium was somewhat surprising and
remains difficult to interpret. One possibility is that in the rat
serum, magnesium levels are better indicators of the severity of
uremia than the BUN, and its relationship to cerebral calcium
merely reflects the effect of uremia. A direct effect of extracel-
lular magnesium could be postulated, but there is no definitive
evidence to support such a hypothesis. In in vivo studies,
Blaustein, Ratzlaff, and Kendrick [341 showed that ATP-
depended calcium uptake by rat brain synaptosomes requires
extracellular magnesium; on the other hand, Kamino et al [35]
demonstrated inhibition by magnesium of non-ATP-dependent
calcium binding by rat synaptosomes. It should be noted that in
both these studies, the extrasynaptosomal calcium concentra-
tion was well below normal physiological levels.
In general, our results of cerebral calcium concentrations, as
well as those of other investigators must be interpreted with
great caution, since it is very dubious whether the calcium
content of any tissue homogenate actually indicates the level of
intracellular calcium. A number of studies in a variety of tissues
have shown that 50 to 90% of total tissue calcium may be bound
to extracellular ligands [12—14], making it quite feasible that any
alteration in the measured calcium content of tissue merely
reflects an alteration in the calcium bound extracellularly.
Within the cell, however, specific subcellular compartments
contain distinct quantities of calcium. Of these, the mito-
chondrial pooi contains the largest proportion of the intracellu-
lar calcium ranging between 30 and 65% in most tissues [12, 15,
16]. Furthermore, there is very compelling evidence that in cells
other than erythrocytes and striated muscle, the mitochondria
are the primary regulators of the cytosolic calcium activity
[17—20]. Mitochondria isolated from most tissue are capable of
reducing the external calcium concentration to below l06 M
and both the rate and capacity of calcium sequestration exceed
those of the plasma membrane and endoplasmic reticulum by at
least one order of magnitude [12, 17, 201. Calcium accumulation
by mitochondria is thought to be a component of the mechanism
which keeps cytosolic calcium at io that of the extracellular
space, and thereby buffers any excess calcium which may enter
the cell. This has been shown for liver, kidney, muscle, and
brain [36—391. Other calcium sequestering systems have been
described for brain [40] and are important in short-term regula-
tion of intracellular calcium as may occur following an action
potential. Mitochondria, however, have a larger overall capac-
ity and are thought to be particularly important for the brain in
situations of excessive calcium loads [39, 41]. Consequently,
analysis of mitochondrial calcium should more closely parallel
the intracellular calcium content than whole tissue homogenates.
Our results demonstrate that mitochondrial calcium remains
unchanged despite the presence of significant renal failure.
Multiple regression analysis indicates that the mitochondrial
calcium concentration correlates directly with serum calcium
levels and surprisingly with i-PTH, but not with the severity of
renal failure as reflected by either the BUN or serum magne-
sium. This would suggest that although brain homogenates have
an increased calcium content in severely uremic rats, intracel-
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lular calcium as reflected by mitochondrial calcium is not
elevated. The role of PTH is not clear, but it is intriguing to
speculate that elevated PTH is necessary for maintaining a
normal intracellular calcium concentration in a setting where
there could otherwise develop a reduction in intracellular
levels. If normal intracellular calcium levels are in part depen-
dent on the extracellular calcium concentration, and if uremia is
associated with an increase in calcium precipitation or binding
to extracellular ligands, it is quite reasonable to conclude that
increased PTH counteracts a trend toward a reduction in
exchangeable extracellular calcium.
The mechanism by which PTH accomplishes this for the
brain must as yet remain speculative although several mecha-
nisms are possible. The simplest would be that the increased
levels of PTH maintain the extracellular calcium at normal
levels thereby indirectly maintaining normal intracellular levels.
Another possibility is that PTH directly affects calcium trans-
port into the brain. In tissues for which PTH receptors are
recognized PTH does result in a net increase in cellular calcium
in vitro [12]. This, however, is a less likely explanation as it has
not to date been reported that the brain is a target organ for
PTH.
Of course, it is quite possible that the failure to demonstrate
increased mitochondrial calcium in renal failure may be due to
intrinsic abnormalities of mitochondrial calcium cycling and an
impairment of their calcium buffering ability induced by uremia.
Although this problem was not addressed directly by the study,
the fact that a similar relationship between serum calcium and
mitochondrial calcium was demonstrated in both normal and
uremic groups would suggest that calcium cycling is not grossly
impaired.
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